SEC Form DFiling only, no announcement found
Glycotest, based in Merion Station, PA, reported $3,220,105 sold in a private offering of equity, with the first sale on June 30, 2026, in a Form D filed with the SEC on July 16, 2026. The filing says 3 investors have already invested. The offering authorizes up to $6,798,345.
Legal name on the filing: Glycotest Inc..
| Amount sold | $3,220,105Basis: Form D total amount sold, as of the filing of July 16, 2026. Not the announced round size. |
|---|---|
| Total offering | $6,798,345The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $3,578,240 |
| Securities offered | Equity |
| Exemption claimed | Rule 506(b) |
| Date of first sale | June 30, 2026 |
| Investors already invested | 3 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Other Health Care |
| Principal place of business | Merion Station, PA |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | over five years ago |
| Revenue range | Decline to Disclose |
| SEC CIK | 2144866 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Charles Swindell | Executive Officer, Director | None linked |
| Ilian Iliev | Director | None linked |
| Ed Hooper | Director | None linked |
| Jenny Jiang | Director | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Jul 16, 2026 | D (original) | $3,220,105 | $6,798,345 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through September 29, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Glycotest: SEC Form D deal record", https://vcbeast.com/deals/glycotest-form-d-2026-06-30. Source: SEC EDGAR, accession 0002144866-26-000001.